NDC Package 0003-0215-01 Daklinza

View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

0003-0215-01

Package Description:

28 TABLET in 1 BOTTLE

Product Code:

0003-0215

Proprietary Name:

Daklinza

Usage Information:

Daclatasvir is used with another antiviral medication (sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Daclatasvir should never be used without sofosbuvir. Daclatasvir and sofosbuvir may also be used with another antiviral medication (ribavirin). These medications together reduce the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer. It is not known if this treatment can prevent you from passing the virus to others. Do not share needles, and practice "safer sex" (including the use of latex condoms) to lower the risk of passing the virus to others.

11-Digit NDC Billing Format:

00003021501

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

28 EA

Labeler Name:

E.r. Squibb & Sons, L.l.c.

Sample Package:

FDA Application Number:

NDA206843

Marketing Category:

NDA - A product marketed under an approved New Drug Application.

Start Marketing Date:

07-27-2015

End Marketing Date:

12-31-2019

Listing Expiration Date:

12-31-2019

Exclude Flag:

Code Structure:

0003 - E.r. Squibb & Sons, L.l.c.
- 0003-0215 - Daklinza
  - 0003-0215-01 - 28 TABLET in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0003-0215-01?

The NDC Packaged Code 0003-0215-01 is assigned to a package of 28 tablet in 1 bottle of Daklinza, labeled by E.r. Squibb & Sons, L.l.c.. The product's dosage form is and is administered via form.

Is NDC 0003-0215 included in the NDC Directory?

No, Daklinza with product code 0003-0215 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by E.r. Squibb & Sons, L.l.c. on July 27, 2015 and its listing in the NDC Directory is set to expire on December 31, 2019 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 0003-0215-01?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 28.

What is the 11-digit format for NDC 0003-0215-01?

The 11-digit format is 00003021501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
4-4-2	0003-0215-01	5-4-2	00003-0215-01

Table of Contents